Company logo

DOC - Physicians Realty Trust

NYSE -> Real Estate -> REIT—Healthcare Facilities
Milwaukee, United States
Type: Equity

DOC price evolution
DOC
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $156.78 $195.77 $245.66 $3.36
Short term investments
Net receivables $11.96 $11.13 $8.29 $10.83
Inventory
Total current assets $274.51 $311.89 $357.82 $117.05
Long term investments
Property, plant & equipment $4834.33 $4839.42 $4875.89 $4899.92
Goodwill & intangible assets $314.16 $339.19 $364.45 $391.96
Total noncurrent assets
Total investments $1001.3 $971.26 $945.99 $957.83
Total assets $5155.62 $5212.47 $5279.54 $5061.17
Current liabilities
Accounts payable $8.36 $4.93 $4.21 $3.34
Deferred revenue $905.63 $879.17 $881.87 $878.44
Short long term debt
Total current liabilities $270.48 $266.3 $262.74 $253.03
Long term debt $1973.04 $1972.26 $2007.61 $1762.69
Total noncurrent liabilities
Total debt $2077.88 $2077.06 $2112.31 $1867.55
Total liabilities $2266.09 $2261.73 $2293.56 $2039.52
Shareholders' equity
Retained earnings -$1061.29 -$1012.87 -$969.74 -$926.79
Other shareholder equity $0.72 $15.22 $9.28 $4.16
Total shareholder equity $2763.53 $2822.28 $2855.79 $2890.26
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $156.78 $7.73 $9.88 $2.52
Short term investments
Net receivables $11.96 $112.81 $4.95 $4.76
Inventory
Total current assets $274.51 $120.54 $110.27 $93.8
Long term investments
Property, plant & equipment $4834.33 $4748.15 $5036.3 $4262.68
Goodwill & intangible assets $314.16 $418.06 $519.76 $519.92
Total noncurrent assets
Total investments $1001.3 $1081.51 $864.15 $642.95
Total assets $5155.62 $5096.88 $5182.71 $4413.95
Current liabilities
Accounts payable $8.36 $4.39 $6.65 $7.01
Deferred revenue $905.63 $844.08 $789.21 $774.32
Short long term debt
Total current liabilities $270.48 $257.27 $255.11 $220.3
Long term debt $1973.04 $1818.12 $1911.92 $1438.85
Total noncurrent liabilities
Total debt $2077.88 $1923.13 $2016.88 $1512.97
Total liabilities $2266.09 $2223.9 $2188.59 $1670.66
Shareholders' equity
Retained earnings -$1061.29 -$881.67 -$776 -$658.17
Other shareholder equity $0.72 $5.18 -$0.89 -$5.86
Total shareholder equity $2763.53 $2869.72 $2836.31 $2641.3
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $135.47 $138.55 $135.1 $134.34
Cost of revenue $44.57 $47.63 $45.08 $45.39
Gross Profit $90.91 $90.92 $90.03 $88.95
Operating activities
Research & development
Selling, general & administrative $7.62 $9.77 $10.16 $11.2
Total operating expenses $62.09 $57.7 $58.11 $58.88
Operating income $28.81 $33.22 $31.92 $30.07
Income from continuing operations
EBIT $28.31 $32.38 $33.18 $29.36
Income tax expense
Interest expense $21.51 $20.05 $20.63 $19.15
Net income
Net income $6.79 $12.34 $12.54 $10.2
Income (for common shares) $6.79 $12.34 $12.54 $10.2
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $543.46 $526.63 $457.7 $437.5
Cost of revenue $182.66 $171.1 $137.41 $128.2
Gross Profit $360.8 $355.54 $320.29 $309.31
Operating activities
Research & development
Selling, general & administrative $38.76 $40.21 $37.76 $33.76
Total operating expenses $236.78 $229.85 $195.97 $188.22
Operating income $124.02 $125.69 $124.32 $121.08
Income from continuing operations
EBIT $123.23 $176.6 $144.1 $123.3
Income tax expense
Interest expense $81.35 $72.23 $60.14 $57.18
Net income
Net income $41.88 $104.37 $83.97 $66.12
Income (for common shares) $41.88 $104.37 $83.95 $64.88
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $6.79 $12.34 $12.54 $10.2
Operating activities
Depreciation $47.54 $47.93 $47.95 $47.68
Business acquisitions & disposals -$9.38 -$1.02 $1.27 -$0.18
Stock-based compensation $3.39 $3.97 $3.65 $4.67
Total cash flows from operations $67.52 $60.13 $82.07 $63.72
Investing activities
Capital expenditures -$19.71 -$23.28 -$47.86 -$9.45
Investments -$18.66 $8.93 $20.82 -$10.96
Total cash flows from investing -$49.3 -$16.14 -$26.81 -$21.77
Financing activities
Dividends paid -$54.94 -$54.94 -$54.91 -$55.64
Sale and purchase of stock $0.34 -$0.19 $0.22 $65.81
Net borrowings -$0.26 -$36.4 $243.95 -$56.27
Total cash flows from financing -$57.21 -$93.87 $187.04 -$46.32
Effect of exchange rate
Change in cash and equivalents -$38.99 -$49.89 $242.3 -$4.37
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $41.88 $104.37 $83.97 $66.12
Operating activities
Depreciation $191.09 $189.64 $157.87 $149.59
Business acquisitions & disposals -$9.32 -$13.59 -$9.85 -$18.57
Stock-based compensation $15.68 $15.67 $15.03 $12.49
Total cash flows from operations $273.43 $258.4 $247.56 $233.3
Investing activities
Capital expenditures -$100.3 -$29.14 -$658.03 -$86.66
Investments $0.13 $8.38 $68.66 -$94.03
Total cash flows from investing -$114.02 -$38.47 -$603.22 -$201.91
Financing activities
Dividends paid -$220.43 -$209.42 -$198.84 -$187.99
Sale and purchase of stock $66.18 $99.28 $261.89 $363.87
Net borrowings $151.03 -$97.17 $461.04 -$198.54
Total cash flows from financing -$10.36 -$222.07 $363.03 -$31.22
Effect of exchange rate
Change in cash and equivalents $149.05 -$2.15 $7.36 $0.16
Fundamentals
Market cap $4.37B
Enterprise value $6.29B
Shares outstanding 238.52M
Revenue $543.46M
EBITDA $314.32M
EBIT $123.23M
Net Income $41.88M
Revenue Q/Q 2.19%
Revenue Y/Y N/A
P/E ratio 104.29
EV/Sales 11.57
EV/EBITDA 20.01
EV/EBIT 51.03
P/S ratio 8.04
P/B ratio 1.58
Book/Share 11.58
Cash/Share 0.66
EPS $0.18
ROA 0.81%
ROE 1.48%
Debt/Equity 0.82
Net debt/EBITDA 6.71
Current ratio 1.01
Quick ratio 1.01